Purpose: to analyze the relation between Trauma Quality Indicators (QI) and death, as well as clinical adverse events in severe trauma patients. Methods: analysis of data collected in the Trauma Register between 2014-2015, including patients with Injury Severity Score (ISS) > 16, reviewing the QI: (F1) Acute subdural hematoma drainage > 4 hours with Glasgow Coma Scale (GCS) <9; (F2) emergency room transference without definitive airway and GCS <9; (F3) Re-intubation within 48 hours; (F4) Admission-laparotomy time greater than 60 min in hemodynamically instable patients with abdominal bleeding; (F5) Unprogrammed reoperation; (F6) Laparotomy after 4 hours; (F7) Unfixed femur diaphyseal fracture; (F8) Non-operative treatment for abdominal gunshot; (F9) Admission-tibial exposure fracture treatment time > 6 hours; (F10) Surgery > 24 hours. T the chi-squared and Fisher tests were used to calculate statistical relevance, considering p<0.05 as relevant. Results: 127 patients were included, whose ISS ranged from 17 to 75 (28.8 + 11.5). There were adverse events in 80 cases (63%) and 29 died (22.8%). Twenty-six patients had some QI compromised (20.6%). From the 101 patients with no QI, 22% died, and 7 of 26 patients with compromised QI (26.9%) (p=0.595). From the patients with no compromised QI, 62% presented some adverse event. From the patients with any compromised QI, 18 (65.4%) had some adverse event on clinical evolution (p=0.751). Conclusion: the QI should not be used as death or adverse events predictors in severe trauma patients.
Introduction: The association between preeclampsia (PE), known as a disorder of pregnancy characterized by the onset of systemic arterial hypertension, and the promotion of neurodevelopmental disorders has been hypothesized by several studies. Indeed, it is believed that multifactorial psychiatric conditions may arise after a compromised anatomical and functional brain development due to low oxygen levels. However, a solid relation between intrauterine hypoxia and potential subsequent neurodevelopmental deficits remains unknown. Therefore, studies in animal models of PE become essential for understanding this specific cause and effect from a behavioral perspective. The aim of this study was to evaluate behavioral alterations in 2-month-old (P60) male rats from females Wistars treated with L-NAME, a hypertensive agent that inhibits nitric oxide synthase (NOS). In addition, we sought to identify a possible protective effect of Sildenafil Citrate (CS), a potent vasodilator, against PE. Methodology: Firstly, pregnant female Wistar rats were treated by gavage, daily, from the 1st to the 18th day of pregnancy (DP) with L-NAME (50 mg/kg) and with CS (10 mg/kg) from the 7th to the 18th DP. Control animals were treated with similar volumes of pure water. The pups were then divided accordingly: 1) Control; 2) L-NAME; 3) CS; 4) L-NAME+CS. The behavioral tests were performed in P60 animals; the male rats were subjected to open field, social interaction, sucrose preference and contextual fear conditioning tests. The results were analyzed by One Way ANOVA with Bonferroni’s post-hoc. Data are presented as mean ± SD (in % of Control group). Results: As expected, the SBP (Systolic Blood Pressure) was significantly elevated in L-NAME treated rats than in controls (149.40 ± 15.45 versus 100.40 ± 2.37, p<0.0001). Still, it was possible to notice a reduction in SBP after the concomitant administration of L-NAME and CS in comparison to L-NAME group (117.00 ± 17.79 versus 149.40 ± 15.45, p<0.0001). No significant differences were verified among all groups evaluated in the open field or social interaction tests (p>0.05). However, the L-NAME group showed a decrease in sucrose preference test (64.12 ± 10.98, p<0.05). Lastly, the results of contextual fear conditioning test pointed towards a reduction in freezing time in L-NAME animals in comparison to the Control group (33.89 ± 33.96 versus 193.00 ± 122.00, p<0.01). Discussion: L-NAME administration induces an increase in SBP that possibly can lead to intrauterine hypoxia and may explain anhedonia and cognitive impairments observed in preeclampsia-like rats. Curiously, such phenotypes are important features of several neurodevelopmental disorders, like Intellectual Disability, Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder, as well as the prodromal phase of Schizophrenia. Our study also indicates that CS administration reverses part of the behavioral alterations observed after PE. Conclusion: Increased SBP during pregnancy promotes intrauterine hypoxia, which seems to be a crucial factor in triggering behavioral alterations that are consistent with neurodevelopmental disorders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.